SCHOTT PHARMA AG & CO. KGAA

Press Releases SCHOTT Pharma AG & Co. KGaA

Equities

1SXP

DE000A3ENQ51

Market Closed - Xetra Other stock markets 11:35:18 2024-05-09 am EDT			5-day change	1st Jan Change
37.02 ^EUR	-4.34%		-5.85%	+10.18%

Apr. 22	SCHOTT PHARMA : Jefferies remains Neutral	ZD
Apr. 11	Gerresheimer very weak - Certain uncertainties about outlook	DP

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations	Apr. 30	EQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina	Mar. 19	AQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility	Mar. 18	EQ
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda	Mar. 14	EQ
DD: SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell	Mar. 04	EQ
SCHOTT Pharma reports good start into fiscal year 2024	Feb. 29	EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	Feb. 26	EQ
SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory	Jan. 26	EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Jan. 15	EQ
SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance	Dec. 19	EQ
Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company	Dec. 06	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW